Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Assets Average (2021 - 2025)

Historic Assets Average for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $114.6 million.

  • Burning Rock Biotech's Assets Average fell 1846.51% to $114.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.6 million, marking a year-over-year decrease of 1846.51%. This contributed to the annual value of $133.9 million for FY2024, which is 2890.63% down from last year.
  • As of Q3 2025, Burning Rock Biotech's Assets Average stood at $114.6 million, which was down 1846.51% from $116.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Assets Average high stood at $518.0 million for Q4 2021, and its period low was $114.6 million during Q3 2025.
  • For the 5-year period, Burning Rock Biotech's Assets Average averaged around $244.8 million, with its median value being $195.0 million (2023).
  • In the last 5 years, Burning Rock Biotech's Assets Average skyrocketed by 2620.37% in 2021 and then tumbled by 5599.08% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Assets Average (Quarter) stood at $518.0 million in 2021, then crashed by 54.29% to $236.8 million in 2022, then crashed by 35.3% to $153.2 million in 2023, then decreased by 14.61% to $130.8 million in 2024, then dropped by 12.38% to $114.6 million in 2025.
  • Its Assets Average was $114.6 million in Q3 2025, compared to $116.5 million in Q2 2025 and $119.5 million in Q1 2025.